Student Publications

2017

Chang AY, Dao T, Gejman RS, Jarvis CA, Scott A, Dubrovsky L, Mathias MD, Korontsvit T, Zakhaleva V, Curcio M et al..  2017.  A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens.. J Clin Invest. 127(7):2705-2718.
2017
Pulecio J, Verma N, Mejía-Ramírez E, Huangfu D, Raya A.  2017.  CRISPR/Cas9-Based Engineering of the Epigenome.. Cell Stem Cell. 21(4):431-447.
2017
Liang H, Zheng Q-L, Fang P, Zhang J, Zhang T, Liu W, Guo M, Robinson CL, Chen S-B, Chen X-P et al..  2017.  Targeting the PI3K/AKT pathway via GLI1 inhibition enhanced the drug sensitivity of acute myeloid leukemia cells.. Sci Rep. 7:40361.
2017

2016

Dubin K, Callahan MK, Ren B, Khanin R, Viale A, Ling L, No D, Gobourne A, Littmann E, Huttenhower C et al..  2016.  Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis.. Nat Commun. 7:10391.
2016
Coppo M, Chinenov Y, Sacta MA, Rogatsky I.  2016.  The transcriptional coregulator GRIP1 controls macrophage polarization and metabolic homeostasis.. Nat Commun. 7:12254.
2016
Guryanova OA, Shank K, Spitzer B, Luciani L, Koche RP, Garrett-Bakelman FE, Ganzel C, Durham BH, Mohanty A, Hoermann G et al..  2016.  DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling.. Nat Med. 22(12):1488-1495.
2016
See SK, Hoogendoorn S, Chung AH, Ye F, Steinman JB, Sakata-Kato T, Miller RM, Cupido T, Zalyte R, Carter AP et al..  2016.  Cytoplasmic Dynein Antagonists with Improved Potency and Isoform Selectivity.. ACS Chem Biol. 11(1):53-60.
2016
Halberg N, Sengelaub CA, Navrazhina K, Molina H, Uryu K, Tavazoie SF.  2016.  PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion.. Cancer Cell. 29(3):339-353.
2016
Brown TR, Krogh-Madsen T, Christini DJ.  2016.  Illuminating Myocyte-Fibroblast Homotypic and Heterotypic Gap Junction Dynamics Using Dynamic Clamp.. Biophys J. 111(4):785-797.
2016